Literature DB >> 18694919

Gene expression analysis of Dupuytren's disease: the role of TGF-beta2.

A Y Zhang1, K D Fong, H Pham, R P Nacamuli, M T Longaker, J Chang.   

Abstract

Dupuytren's disease is characterised by nodular fibroblastic proliferation of the palmar fascia leading to contracture of the hand. Transforming growth factor beta (TGF-beta) is thought to play a role in its pathogenesis. We performed a cDNA microarray analysis of Dupuytren's diseased cord tissue with an emphasis on TGF-beta isoforms. Normal-appearing transverse ligament of the palmar fascia from adjacent to the diseased cord and palmar fascia from patients undergoing carpal tunnel release were used as controls. TGF-beta gene expression was confirmed by quantitative real-time polymerase chain reaction. Over 20 unique genes were found to be significantly up-regulated, including several previously reported genes. A dominant increase in TGF-beta2 expression was seen in the cord tissue, whereas TGF-beta1 and TGF-beta3 were found not to be significantly up-regulated. Quantitative real-time polymerase chain reaction confirmed these findings. This gene expression profile allows for further experiments that may eventually lead to gene therapy to block the development and progression of Dupuytren's disease clinically.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18694919     DOI: 10.1177/1753193408091352

Source DB:  PubMed          Journal:  J Hand Surg Eur Vol        ISSN: 0266-7681


  8 in total

1.  Update on the role of molecular factors and fibroblasts in the pathogenesis of Dupuytren's disease.

Authors:  Massimiliano Tripoli; Adriana Cordova; Francesco Moschella
Journal:  J Cell Commun Signal       Date:  2016-06-07       Impact factor: 5.782

2.  Evaluation of a mitochondrial DNA mutation in maternally inherited and sporadic cases of Dupuytren disease.

Authors:  Eric R Anderson; James K Burmester; Michael D Caldwell
Journal:  Clin Med Res       Date:  2012-05-25

Review 3.  Scientific understanding and clinical management of Dupuytren disease.

Authors:  Barbara Shih; Ardeshir Bayat
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

4.  In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related properties.

Authors:  Farhatullah Syed; Alexis N Thomas; Subir Singh; Venkatesh Kolluru; Susan G Emeigh Hart; Ardeshir Bayat
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

5.  Integrative genomic and transcriptomic analysis of genetic markers in Dupuytren's disease.

Authors:  Junghyun Jung; Go Woon Kim; Byungjo Lee; Jong Wha J Joo; Wonhee Jang
Journal:  BMC Med Genomics       Date:  2019-07-11       Impact factor: 3.063

6.  Genome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren's disease.

Authors:  Helen B Forrester; Peter Temple-Smith; Seungmin Ham; David de Kretser; Graeme Southwick; Carl N Sprung
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

7.  Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren's Disease.

Authors:  Kerstin Becker; Sabine Siegert; Mohammad Reza Toliat; Juanjiangmeng Du; Ramona Casper; Guido H Dolmans; Paul M Werker; Sigrid Tinschert; Andre Franke; Christian Gieger; Konstantin Strauch; Michael Nothnagel; Peter Nürnberg; Hans Christian Hennies
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

Review 8.  Connective Tissue Degeneration: Mechanisms of Palmar Fascia Degeneration (Dupuytren's Disease).

Authors:  S Karkampouna; M Kreulen; M C Obdeijn; P Kloen; A L Dorjée; F Rivellese; A Chojnowski; I Clark; Marianna Kruithof-de Julio
Journal:  Curr Mol Biol Rep       Date:  2016-07-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.